INSIGHTS ON DRUG DEVELOPMENT
-
Assessment Of Compound Toxicity Effects With High-Content Imaging
3D cellular models and bioprinting enhance drug safety predictions and offer precise spatial control. Explore an automated method for generating liver models to improve reproducibility and reliability in toxicity testing.
-
How The Acceleratorâ„¢ Drug Development Model Enhances eNPV
Discover how an integrated CDMO and CRO model can accelerate development timelines, add up to $62.9 million in value, and help you maximize long-term pipeline success with a single, streamlined partner.
-
Solving Bioavailability Challenges In bRo5 Drugs
Leverage mechanistic, material-sparing formulation strategies to enhance bioavailability and accelerate development of challenging bRo5 small molecules, even with limited resources.
-
Scale-Up Of A Transient rAAV Production Process
Scalable rAAV production is achievable with a transient cell line and optimized bioreactor setup, delivering high titers and reduced impurities, now validated at 200 L scale for commercial readiness.
-
Utilizing The Colon Intestine-Chip To Investigate Mechanisms Of Gastrointestinal Disease8/2/2024
What are the application and benefits of Organ-Chips and what makes them superior to organoids in the study of GI-related diseases?
-
AI Based Screening And Selection Of Co-Formers For Co-Crystallization11/4/2025
Explore how AI and quantum chemistry are accelerating co-crystal screening and solving solubility challenges in drug development, as well as key technical considerations for identifying optimal co-formers.
-
Bioprocess Training And Education3/17/2026
Advance from development to manufacturing with expert-led, hands-on, or virtual courses that strengthen process understanding and scale-up skills designed to support every stage of your molecule’s journey.
-
Inside Asymchem's Advanced R&D Capabilities In The UK2/12/2026
Advanced experimentation, unified workflows, and continuous manufacturing are accelerating small‑molecule development, improving insight and creating more efficient paths from discovery to scale.
-
Making Accelerated Predictive Stability Studies Even Faster With Software6/18/2026
Drug stability depends on environmental conditions, but testing every scenario experimentally isn’t practical. Accelerated predictive stability uses mathematical modeling to forecast degradation, helping scientists make faster, data-driven decisions early in development.
DRUG DEVELOPMENT SOLUTIONS
-
Ensure patient safety and product efficacy with high-quality pharmaceutical excipients that are designed to streamline regulatory approval and support sterile liquid drug formulation development.
-
Minimize variability and improve detection confidence with high-purity analytical solvents. Discover how tightly controlled specifications support cleaner baselines and more reliable results.
-
Discover how collaboration and reliability drive meaningful impact across the healthcare and life sciences industries by empowering innovation from lab to clinic.
-
Ergonomic system microscope Leica DM1000 LED
The Leica DM1000 LED features long-life LED illumination that provides near daylight, bright illumination with constant color temperature and emits less heat.
The LED also eliminates the need for lamp changes, which saves time and money. Because of its low power consumption, the system is energy efficient. Users of the Leica DM1000 LED benefit from the system’s ability to uniquely adapt to every user.
It is ideal for all clinical laboratory applications, especially for cytology, haematology, and pathology. For special diagnostics requirements, the microscope is certified for in-vitro-diagnostics (IVD) like in-vitro-fertilization (IVF).